Ask your doctor for the #1 prescribed brand for severe eosinophilic asthma
Source: IQVIA - NPA® audit 12 mo. TRx data ending 4/19 (All rights reserved).
NUCALA is an add-on, prescription maintenance treatment for patients 6 and older with severe eosinophilic asthma. NUCALA is not used to treat sudden breathing problems.
Helps prevent severe asthma attacks
Reduces the need for oral steroids
Better breathing*
Easy-to-use, at-home administration option for people 12+
Want more? Have helpful information, tools, and tips sent to your inbox.
Sign up now for more about NUCALA.
By submitting this, you certify that you are at least 18 years old.
GlaxoSmithKline (GSK) believes your privacy is important. By providing your name, address, email address, and other information, you are giving GSK and companies working with GSK permission to market or advertise to you across multiple digital and offline channels, or contact you for market research or other purposes, regarding the medical condition(s) in which you have expressed an interest, as well as other health-related information from GSK. GSK will not sell or transfer your name, address, or email address to any other party for their own marketing use. For additional information regarding how GSK handles your information, please see our privacy statement.
